Betterhood Raises ₹11.5 Crore to Build India’s Pain-Care Market

Bengaluru-based Betterhood has raised ₹11.5 crore in a seed funding round led by Sauce VC, with existing backer Kairon Capital also participating. The startup builds preventive pain-care products think posture supports, orthotic soft goods, and recovery gear aimed at people before chronic pain sets in.

This isn't Betterhood's first close this year. The company raised ₹5 crore in March, also from Kairon Capital and a set of consumer-brand angels. Add the two together, and Betterhood's total seed capital now stands at roughly ₹16.5 crore in under seven months.

That pace of back-to-back closes, for a brand barely a year old, is the real story here not just the headline number.

The Details

• Latest round: ₹11.5 crore, seed
• Lead investor: Sauce VC
• Participating: Kairon Capital (existing)
• Earlier tranche: ₹5 crore in March 2026, led by Kairon Capital, with angels Yogesh Kabra (XYXX), Rishubh Satiya (Plix), Rohit Chawla and Sifat Khurana (Innovist), and Shayamal Vallabhjee
• Combined seed capital: ~₹16.5 crore across two tranches
• Founded: October 2024, by Vikram Kadam and Neha Zade

Selling Pain Prevention, Not Pain Relief

Most pain-care brands in India sell after the fact you already hurt, now buy a support belt. Betterhood is positioning earlier in that funnel: posture correctors, ergonomic supports, and orthotic soft goods for back, knee, ankle and wrist, meant to be bought before an issue becomes chronic.

That's a harder sell. Prevention products don't have the urgency of pain relief.

Betterhood's answer is building a trust layer around the products. It runs Physio Circle, a network of over 7,000 physiotherapists, and The Physio Edge, a certification course for early-career physios. The company also claims 2+ lakh customers served and 1,500 pieces of educational content published.

That's a services-and-content moat wrapped around a physical product line a more capital-intensive strategy than a pure DTC brand, but one that's harder for a competitor to copy quickly.

A ₹20,000 Cr Market, Still Mostly Offline

Betterhood pegs its current addressable market at around ₹20,000 crore, growing at a low-to-mid-teens rate. Widen the lens to rehab, fitness tools and personalised nutrition, and the company claims the opportunity swells to ₹35,000 crore.

The underlying demand data backs the pitch: over half of Indian adults above 45 live with musculoskeletal pain, and the onset age keeps dropping a trend accelerated by desk jobs and remote work.

But Betterhood isn't alone in reading this signal. Established players like Tynor and Vissco already dominate offline orthotic retail, and Nivaan Care recently raised $7 Mn to scale non-surgical chronic-pain clinics a different wedge into the same broad pain-care market.

The fresh capital goes toward deepening the product line, pushing into quick commerce and modern retail, and scaling both the content engine and the physiotherapist community.

What the Fast Follow-On Signals

Two seed closes in seven months usually means one of two things: investors saw traction and wanted in before a priced round, or the company under-raised the first time and had to come back sooner than planned. Betterhood frames it as validation but 7 months is fast even for a hot category. Worth watching: orthotic supports fall under India's Medical Devices Rules, even at the lowest-risk self-notification tier. That means every product claim Betterhood makes is a regulated statement, not just copywriting a compliance layer that DTC wellness brands don't usually have to think about this early.

The Bottom Line

Betterhood is betting that education and a physiotherapist network can out-compete brands that just sell the support belt the next raise will show whether that moat is actually converting into retail-scale revenue.